Support Us

Early-Stage Summer Sprint

From Idea to World Stage

The Early-Stage Summer Sprint is a national accelerator designed to support early- stage business ventures and develop innovative social enterprises, community initiatives, and impact-driven ventures aligned with the Sustainable Development Goals (SDGs).   

The program has finished for this year. Congratulations to LimbRise from University of PEI. This venture will be competing at the Enactus World Cup in November. 

Program Details
June 15
6-week program starts
100% Virtual
Interactive sessions
 

Mentorship 

Support throughout sprint

Individual or team
All postsecondary students
SDG aligned
Impact-driven ventures

LimbRise, a mobility aid for knee injuries from the University of Prince Edward Island, is the winner of the Early-Stage Summer Sprint National Final. The team will represent Canada at the Early-Stage competition final at the Enactus World Cup, in...

Read More
  •  ClinIQ, University of British Columbia: A healthcare platform designed to help patients get to the right care faster, while reducing the administrative load on physicians — built to work alongside the tools clinics already use.
     
  • EchoLoop, University of British Columbia: A sustainable materials innovation that gives textile waste a second life as a functional building product, with a strong eye toward real-world performance standards.
     
  • ForeSite, Southern Alberta Institute of Technology: A tech-driven solution to help predict and manage environmental risk, combining established science with modern data tools on a clear path from prototype to scale. 
     
  • GrainCycle, McGill University: A circular-economy venture turning a common industry byproduct into a new consumer product, with a business model designed around multiple revenue streams from a single waste problem.
     
  • LimbRise, University of Prince Edward Island: A recovery-focused innovation for knee injuries, designed to make mobility aids more comfortable and keep patients connected to care between clinical visits. Built on deep patient research and a clear path to market.